Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

MAZEMaze Therapeutics, Inc.

$2B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$165M

Gross Profit

$165M100.0% margin

Operating Income

$140M84.6% margin

Net Income

$139M84.3% margin

EPS (Diluted)

$0.98

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

$145M

Free Cash Flow

$145M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$216M

Total Liabilities

$478M

Stockholders' Equity

-$262M

Cash & Equivalents

$175M

← FY 2024 All Quarters Q3 2024 →

MAZE Q2 2024 Earnings — Maze Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena